BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 21235451)

  • 21. High salt intake impairs vascular nitric oxide/cyclic guanosine monophosphate system in spontaneously hypertensive rats.
    Kagota S; Tamashiro A; Yamaguchi Y; Nakamura K; Kunitomo M
    J Pharmacol Exp Ther; 2002 Jul; 302(1):344-51. PubMed ID: 12065736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nitric oxide modulates endothelin 1-induced Ca2+ mobilization and cytoskeletal F-actin filaments in human cerebromicrovascular endothelial cells.
    Chen Y; McCarron RM; Bembry J; Ruetzler C; Azzam N; Lenz FA; Spatz M
    J Cereb Blood Flow Metab; 1999 Feb; 19(2):133-8. PubMed ID: 10027767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroprotection mediated by changes in the endothelial actin cytoskeleton.
    Laufs U; Endres M; Stagliano N; Amin-Hanjani S; Chui DS; Yang SX; Simoncini T; Yamada M; Rabkin E; Allen PG; Huang PL; Böhm M; Schoen FJ; Moskowitz MA; Liao JK
    J Clin Invest; 2000 Jul; 106(1):15-24. PubMed ID: 10880044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myocardial glucose uptake is regulated by nitric oxide via endothelial nitric oxide synthase in Langendorff mouse heart.
    Tada H; Thompson CI; Recchia FA; Loke KE; Ochoa M; Smith CJ; Shesely EG; Kaley G; Hintze TH
    Circ Res; 2000 Feb; 86(3):270-4. PubMed ID: 10679477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endothelial Nitric Oxide Mediates Caffeine Antagonism of Alcohol-Induced Cerebral Artery Constriction.
    Chang J; Fedinec AL; Kuntamallappanavar G; Leffler CW; Bukiya AN; Dopico AM
    J Pharmacol Exp Ther; 2016 Jan; 356(1):106-15. PubMed ID: 26555891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Testosterone Deficiency and Endothelial Dysfunction: Nitric Oxide, Asymmetric Dimethylarginine, and Endothelial Progenitor Cells.
    Hotta Y; Kataoka T; Kimura K
    Sex Med Rev; 2019 Oct; 7(4):661-668. PubMed ID: 30987932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nitric oxide and the cerebral vascular function.
    Lee TJ
    J Biomed Sci; 2000; 7(1):16-26. PubMed ID: 10644885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vascular dysfunction and heart failure: epiphenomenon or etiologic agent?
    Fang ZY; Marwick TH
    Am Heart J; 2002 Mar; 143(3):383-90. PubMed ID: 11868041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of Rho kinase (ROCK) leads to increased cerebral blood flow and stroke protection.
    Rikitake Y; Kim HH; Huang Z; Seto M; Yano K; Asano T; Moskowitz MA; Liao JK
    Stroke; 2005 Oct; 36(10):2251-7. PubMed ID: 16141422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nitric oxide synthase inhibition and cerebrovascular regulation.
    Iadecola C; Pelligrino DA; Moskowitz MA; Lassen NA
    J Cereb Blood Flow Metab; 1994 Mar; 14(2):175-92. PubMed ID: 7509338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Flow-induced dilation is mediated by Akt-dependent activation of endothelial nitric oxide synthase-derived hydrogen peroxide in mouse cerebral arteries.
    Drouin A; Thorin E
    Stroke; 2009 May; 40(5):1827-33. PubMed ID: 19286591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simulated microgravity enhances cerebral artery vasoconstriction and vascular resistance through endothelial nitric oxide mechanism.
    Wilkerson MK; Lesniewski LA; Golding EM; Bryan RM; Amin A; Wilson E; Delp MD
    Am J Physiol Heart Circ Physiol; 2005 Apr; 288(4):H1652-61. PubMed ID: 15576439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endothelial nitric oxide synthase transgenic models of endothelial dysfunction.
    Atochin DN; Huang PL
    Pflugers Arch; 2010 Nov; 460(6):965-74. PubMed ID: 20697735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Poly(ADP-ribose) polymerase inhibition improves erectile function by activation of nitric oxide/cyclic guanosine monophosphate pathway in diabetic rats.
    Li WJ; Peng Y; Zhou J; Li B; Wang H; Zhang J; Wang Z
    J Sex Med; 2012 May; 9(5):1319-27. PubMed ID: 22429732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tetrahydrobiopterin and endothelial function.
    Cosentino F; Lüscher TF
    Eur Heart J; 1998 Jul; 19 Suppl G():G3-8. PubMed ID: 9717048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebral vascular changes during chronic hypertension: good guys and bad guys.
    Heistad DD; Baumbach GL
    J Hypertens Suppl; 1992 Dec; 10(7):S71-5. PubMed ID: 1291659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endothelial dysfunction and stroke.
    Cosentino F; Rubattu S; Savoia C; Venturelli V; Pagannonne E; Volpe M
    J Cardiovasc Pharmacol; 2001 Nov; 38 Suppl 2():S75-8. PubMed ID: 11811384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid nontranscriptional activation of endothelial nitric oxide synthase mediates increased cerebral blood flow and stroke protection by corticosteroids.
    Limbourg FP; Huang Z; Plumier JC; Simoncini T; Fujioka M; Tuckermann J; Schütz G; Moskowitz MA; Liao JK
    J Clin Invest; 2002 Dec; 110(11):1729-38. PubMed ID: 12464678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) and charybdotoxin (CTX) on relaxations of isolated cerebral arteries to nitric oxide.
    Onoue H; Katusic ZS
    Brain Res; 1998 Feb; 785(1):107-13. PubMed ID: 9526059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nitric oxide in the pathogenesis of vascular disease.
    Li H; Förstermann U
    J Pathol; 2000 Feb; 190(3):244-54. PubMed ID: 10685059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.